Patients at the heart: Taiwan’s journey to patient-centred care for Immune-Mediated Inflammatory Diseases

Investment Rating - The report does not explicitly provide an investment rating for the industry. Core Insights - The report emphasizes the need for a patient-centered care model for Immune-Mediated Inflammatory Diseases (IMIDs) in Taiwan, highlighting the increasing burden of these diseases and the inadequacies of the current care pathways [6][10][21]. Summary by Sections About this Report - The report analyzes care pathways for IMIDs in Taiwan, focusing on Inflammatory Bowel Diseases (IBDs), psoriatic diseases, and rheumatoid arthritis (RA), and identifies opportunities for enhancing patient-centered care [6]. Executive Summary - IMIDs affect 3-7% of the global population, leading to significant disabilities. The complexity of these diseases necessitates a multidisciplinary care model rather than a single-specialty approach [10][11]. Known and Unknowns Regarding the Burden of IMIDs in Taiwan - Taiwan has the highest increase in age-standardized incidence rate of IBD globally from 1990 to 2019, with a lack of updated economic burden data [12][30]. Impact of Active Disease on Quality of Life - Active IMIDs significantly impair health-related quality of life (HRQoL), with patients experiencing physical disabilities and psychological distress [13][41]. Gaps in Patient-Centered Care for IMIDs in Taiwan - Delayed diagnosis and lack of mental health support are significant gaps in the current care model. Patients often wait months to years for a diagnosis, and mental health issues are not adequately addressed [17][18][19]. Calls to Action - The report outlines four key actions to improve patient-centered care: addressing inefficiencies in care pathways, developing integrated solutions for IMIDs, adopting a treat-to-target approach, and transitioning to a value-based care model [21][22][23][24]. Conclusion and Calls to Action - The report concludes that a shift towards multidisciplinary, patient-centered care is essential for better disease control and improved quality of life for IMID patients in Taiwan [21][24].